RNU6-632P

Across TCGA pan-cancer cohorts, RNU6-632P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-632P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-632P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-632P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BRCA, KIRC, and STAD are the cancer types where RNU6-632P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.115	0.579	<.001	78	view →
KIRC	OS	Tertile	II,III,IV	0.203	0.789	.009	72	view →
STAD	OS	Tertile	All	0.102	0.736	<.001	36	view →
TGCT	DFS	Tertile	All	0.014	0.837	<.001	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.373	.038	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-632P–BRCA (OS)

Open the BRCA breakdown →